Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The BMT Data Book - Reinhold Munker, Hillard M. Lazarus, Kerry Atkinson

The BMT Data Book

Buch | Softcover
544 Seiten
2009 | 2nd Revised edition
Cambridge University Press (Verlag)
978-0-521-71100-5 (ISBN)
CHF 99,95 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
The BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than a hundred tables, figures and algorithms that reflect up-to-date research and guidance.
The BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments. This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases.

Reinhold Munker is Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, Louisiana State University Health Sciences Center, USA. Hillard M. Lazarus is Professor of Medicine, Case Western Reserve University and Director, Blood and Marrow Transplant Program, University Hospitals Case Medical Center, USA. Kerry Atkinson is Professor of Medicine, University of Queensland, Director of Allogeneic Stem Cell Therapies, Director, Mater Health Services Cell Therapy Quality Management System and Head, Biotherapy Program, Mater Medical Research Institute, Mater Adult Hospital, Australia.

Preface; Introduction; Part I. Basic Science: 1. Basic science; Part II. Hematologic Malignancies: 2. Therapeutic decision making in BMT/SCT for acute myeloid leukemia; 3. Therapeutic decision making in BMT/SCT for acute lymphoblastic leukemia; 4. Therapeutic decision making in BMT/SCT for chronic myeloid leukemia and other myeloproliferative syndromes; 5. Therapeutic decision making in BMT/SCT for chronic lymphatic leukemia; 6. Therapeutic decision making in BMT/SCT for myelodysplasia; 7. Therapeutic decision making in BMT/SCT for non-Hodgkin's lymphoma; 8. Therapeutic decision making in BMT/SCT for Hodgkin's lymphoma; 9. Therapeutic decision making in BMT/SCT for multiple myeloma; 10. Therapeutic decision making in BMT/SCT for amyloidosis; Part III. Solid Tumors: 11. Therapeutic decision making in SCT for breast cancer; 12. Therapeutic decision making in BMT/ SCT for non-seminomatous germ cell tumor of testis (nsgct); 13. Therapeutic decision making in SCT for renal cell cancer; 14. Therapeutic decision making in SCT for soft tissue sarcomas; Part IV. Non-malignant Disorders: 15. Therapeutic decision making in BMT/SCT for severe aplastic anemia; 16. Therapeutic decision making in BMT/SCT for congenital immunodeficiencies; 17. Therapeutic decision making in BMT/SCT for hemoglobinopathies; 18. Therapeutic decision making in BMT/SCT for autoimmune disorders; Part V. Practical Aspects and Procedures: 19. Practical aspects, including conditioning protocols and haploidentical transplantation; 20. Cord blood transplantation; Part VI. Complications: 21. Patho-biology of Graft-versus-host disease; 22. Diagnosis and treatment of graft-versus host disease; 23. Infectious complications; 24. Organ-related and miscellaneous complications; Part VII. The BMT/SCT Pharmacopoeia: 25. The BMT/SCT pharmacopoeia; Part VIII. HLA-testing and Laboratory Medicine: 26. HLA-testing and laboratory medicine: Appendix: Guide to the internet and other databases; Index.

Erscheint lt. Verlag 26.2.2009
Verlagsort Cambridge
Sprache englisch
Maße 155 x 234 mm
Gewicht 900 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 0-521-71100-2 / 0521711002
ISBN-13 978-0-521-71100-5 / 9780521711005
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95